Catherine Ezell
Primary Care · Victorville, CANPI 1144831322
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 94.8% of the total across 86 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 26 manufacturers, the largest accounting for just 13.7% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2021 at $1,181 and has fallen 97.0% since, to $35 in 2025.
Across 86 payments — averaging $22.25 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Astellas Pharma US Inc$263
- Johnson & Johnson$209
- Pharmacyclics LLC, An Abbvie Company$146
- Novo Nordisk$140
- Lilly USA, LLC$136
- Pfizer$125
- plus $893 from 20 others
What the payments were for
- Food & beverage$1,81595%
- Education$995%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Astellas Pharma US Inc | 9 | $263 |
| Johnson & Johnson(2 entities) | 11 | $209 |
| Pharmacyclics LLC, An Abbvie Company | 6 | $146 |
| Novo Nordisk | 4 | $140 |
| Lilly USA, LLC | 8 | $136 |
| Pfizer | 7 | $125 |
| Novartis | 7 | $118 |
| AstraZeneca | 4 | $105 |
| AbbVie | 4 | $91 |
| Boehringer Ingelheim | 3 | $69 |
| Bayer | 3 | $55 |
| Merck | 3 | $54 |
| Melinta Therapeutics, LLC | 1 | $45 |
| Scilex Pharmaceuticals Inc. | 2 | $41 |
| Sanofi | 2 | $39 |
| Incyte Corporation | 2 | $36 |
| Organon | 1 | $35 |
| Karyopharm Therapeutics Inc. | 1 | $33 |
| Amgen | 1 | $27 |
| Dova Pharmaceuticals | 1 | $25 |
| Rigel Pharmaceuticals, Inc. | 1 | $25 |
| Gilead | 1 | $23 |
| Medtronic | 1 | $20 |
| Irhythm Technologies, Inc. | 1 | $18 |
| EMD Serono, Inc. | 1 | $17 |
| Myovant Sciences Inc. | 1 | $16 |
How this compares
$1,914 in reported general payments places this provider in the 85th percentile of 706 primary care providers in California.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Atorvastatin Calcium | 26 | $299 |
| Amlodipine Besylate | 12 | $7 |
Paid to pharmacies, not to this prescriber.
Other primary care in Victorville
- Leslie FletcherTorrance$1.8M
- Hamideh PourzandLos Angeles$103K
- Veronica RamirezSacramento$83K
- Tyson FieldstedBakersfield$65K
- Kathryn CooperSan Diego$31K
- Shalaine Corbillala Mesa$22K
- Paula StoddardHanford$22K
- Ashley LoweSan Diego$19K
- Vanessa LeeLong Beach$16K
- Lynda TranHuntington Beach$16K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.